BPC-157 Research: Complete Guide | Buy Research Peptides ...

For research and laboratory use only. Not for human or veterinary consumption.

BPC-157 (Body Protection Compound-157) is a synthetic peptide consisting of 15 amino acids derived from a larger gastric juice protein known as Body Protection Compound. Since its initial characterization in the 1990s, BPC-157 has attracted significant attention in preclinical research due to its observed effects on tissue repair, gastrointestinal protection, and wound healing processes. This guide provides researchers with a comprehensive overview of BPC-157, covering its chemical properties, proposed mechanisms, research applications, and quality considerations for laboratory procurement.

What Is BPC-157?

BPC-157 is a partial sequence of human gastric juice protein, specifically the pentadecapeptide with the amino acid sequence: GEPPPGKPADDAGLV, MDDKPPGRNDDPPKEGK. It is classified as a stable gastric pentadecapeptide, meaning it remains structurally intact even under the harsh acidic conditions of the stomach and at room temperature for extended periods.

Unlike many synthetic peptides that degrade rapidly in biological fluids, BPC-157 demonstrates remarkable stability. This stability is attributed to its high resistance to proteolytic degradation, which has made it an attractive candidate for oral administration studies in animal models—a route that is unusual for most research peptides.

Chemical Properties

Property	Value
Amino Acid Sequence	GEPPPGKPADDAGLV, MDDKPPGRNDDPPKEGK
Molecular Formula	C62H98N16O22
Molecular Weight	1419.53 g/mol
Peptide Class	Synthetic gastric pentadecapeptide
Solubility	Soluble in water, acetic acid
Stability	Stable at room temperature; resistant to gastric acid
CAS Number	137525-51-0

For researchers procuring BPC-157, the peptide is typically supplied as a lyophilized powder in vials of 5mg or 10mg. Lyophilization preserves the peptide's structural integrity and extends shelf life significantly when stored properly.

Proposed Mechanisms of Action

Preclinical studies have proposed several mechanisms through which BPC-157 may exert its observed biological effects. It is important to note that these mechanisms are derived from in vitro and animal studies, and their relevance to human physiology remains under investigation.

Nitric Oxide System Modulation

One of the most extensively studied proposed mechanisms involves BPC-157's interaction with the nitric oxide (NO) system. Research has suggested that BPC-157 may modulate both constitutive and inducible nitric oxide synthase (cNOS and iNOS) activity. In several animal models, BPC-157 appeared to counteract the effects of L-NAME (an NOS inhibitor), suggesting a role in NO pathway regulation.

VEGF and Angiogenesis

Vascular endothelial growth factor (VEGF) expression has been observed to increase in BPC-157-treated tissues in some studies. VEGF is a critical signaling protein involved in angiogenesis—the formation of new blood vessels from pre-existing vasculature. Enhanced VEGF expression may contribute to the tissue repair processes observed in preclinical models.

Growth Hormone Receptor Pathway

Some research has proposed that BPC-157 may interact with the growth hormone (GH) receptor system, potentially upregulating GH receptor expression in damaged tissues. This proposed mechanism could link to the peptide's observed effects on tendon and ligament healing.

FAK and Paxillin Signaling

Focal adhesion kinase (FAK) and paxillin are key proteins involved in cell migration and cytoskeletal organization. In vitro studies have suggested that BPC-157 may promote FAK phosphorylation and paxillin expression, which could facilitate cell migration during wound healing processes.

Research Applications and Preclinical Studies

BPC-157 has been studied across a wide range of preclinical models. The following sections summarize key research areas.

Wound Healing

Animal studies on wound healing represent one of the largest bodies of BPC-157 research. Studies have examined:

Skin wound closure: Accelerated wound closure in rat models with full-thickness skin defects
Burn wound healing: Observations of improved healing rates in partial-thickness burn models
Surgical wound recovery: Enhanced recovery markers in post-surgical animal models

In many of these studies, BPC-157 was administered both orally and via injection, with researchers noting comparable efficacy across routes—a finding that underscores the peptide's gastric stability.

Gastrointestinal Protection

Given its origin from gastric juice protein, BPC-157 has been extensively studied in gastrointestinal models:

Ulcer protection: Animal models of gastric and intestinal ulcers have shown protective effects
Inflammatory bowel models: Studies in colitis models have observed reduced inflammatory markers
Esophageal healing: Research in esophagitis models has shown improved tissue integrity

Musculoskeletal Research

Preclinical studies on musculoskeletal tissues have examined:

Tendon healing: Accelerated tendon regeneration in surgical transection models
Ligament repair: Improved mechanical properties in ligament healing studies
Bone healing: Enhanced bone density and healing markers in fracture models
Cartilage protection: Observations in osteoarthritis models

Neurological Studies

Emerging research has explored BPC-157 in neurological models:

Peripheral nerve regeneration: Studies on sciatic nerve crush injury models
Spinal cord injury: Preliminary observations in contusion models
Cerebroprotection: Research on ischemia-reperfusion brain injury models

Cardiovascular Research

Some studies have examined BPC-157 in cardiovascular contexts:

Heart protection: Studies in myocardial infarction models
Blood vessel integrity: Research on vascular protection under oxidative stress

BPC-157 Forms: Acetate vs. Base

Researchers encountering BPC-157 will typically find two salt forms available:

BPC-157 Acetate

More commonly available
Generally lower cost
Good solubility in aqueous solutions
Well-characterized in published studies

BPC-157 Base (Free Base)

Sometimes described as having higher purity
Slightly different solubility profile
Fewer published studies using this specific form

For most research applications, either form is suitable. The choice may depend on the specific experimental protocol, solubility requirements, or budget considerations.

Quality Considerations for Research Procurement

When sourcing BPC-157 for research, several quality factors should be evaluated:

Purity

High-performance liquid chromatography (HPLC) purity is the primary quality metric. Research-grade BPC-157 should ideally demonstrate:

HPLC purity ≥ 98%: This is the standard expectation for research peptides
Mass spectrometry confirmation: LC-MS verification of molecular weight
Certificate of Analysis (COA): Complete documentation from the supplier

Learn more about interpreting purity data in our HPLC Purity Testing Guide.

Manufacturing Considerations

Peptide synthesis method: Solid-phase peptide synthesis (SPPS) is the standard approach
Purification method: HPLC purification with subsequent lyophilization
Endotoxin levels: Important for in vitro and in vivo studies
Sterility: Critical for cell culture and injection studies

Documentation

A complete Certificate of Analysis should include:

Amino acid sequence confirmation
HPLC chromatogram with purity percentage
Mass spectrometry data (LC-MS or MALDI-TOF)
Appearance and solubility description
Storage recommendations

For more details on evaluating peptide quality, see our HPLC Purity Testing Quality Guide.

Storage and Handling

Proper storage and handling are essential for maintaining BPC-157 integrity:

Lyophilized Powder

Store at -20°C or below for long-term storage
Protect from light and moisture
Use desiccant packs in storage containers
Shelf life: 2-3 years when properly stored

Reconstituted Solution

Reconstitute with bacteriostatic water or sterile water for injection
Store at 2-8°C after reconstitution
Use within 30 days of reconstitution for optimal stability
Avoid repeated freeze-thaw cycles

For detailed reconstitution protocols, consult our Peptide Reconstitution Complete Guide.

Related Products

Kingston Peptides supplies research-grade BPC-157 in various quantities for laboratory use:

All BPC-157 products from Kingston Peptides include a Certificate of Analysis with HPLC purity data and mass spectrometry confirmation.

Research Limitations and Considerations

Researchers should be aware of important limitations when reviewing BPC-157 literature:

Preclinical data only: The vast majority of BPC-157 research has been conducted in animal models or in vitro systems
Publication bias: Positive results are more likely to be published, potentially skewing the available evidence base
Dosage variability: Studies use a wide range of dosages, making cross-study comparisons challenging
Route of administration: Results may vary significantly between oral, injectable, and topical administration routes
Reproducibility: As with all research, independent replication of findings is essential

Frequently Asked Questions

Q: What is the typical research dosage range for BPC-157? A: Dosages vary widely across studies, ranging from 1-40 μg/kg in animal models. Dosage selection should be based on specific experimental protocols and published literature relevant to the research objective.

Q: Is BPC-157 soluble in water? A: Yes, BPC-157 is soluble in water and dilute acetic acid. For reconstitution guidance, refer to our reconstitution guide.

Q: What analytical methods confirm BPC-157 identity? A: Identity is typically confirmed via LC-MS (liquid chromatography-mass spectrometry) or MALDI-TOF mass spectrometry, with molecular weight matching the expected value of approximately 1419.53 g/mol.

Q: How does BPC-157 compare to TB-500 in wound healing research? A: Both peptides are studied in wound healing contexts but through different proposed mechanisms. BPC-157 research focuses on NO modulation and angiogenesis, while TB-500 (thymosin beta-4) research centers on actin polymerization and cell migration. See our comparison guide for more details.

Conclusion

BPC-157 remains one of the most extensively studied synthetic peptides in preclinical research, with a substantial body of literature covering wound healing, gastrointestinal protection, musculoskeletal repair, and neurological applications. Its remarkable stability and proposed multi-pathway mechanisms make it a versatile research tool.

For researchers procuring BPC-157, prioritizing purity (≥98% HPLC), comprehensive documentation (COA with LC-MS), and proper storage protocols is essential for reproducible results.

Disclaimer: BPC-157 is sold for research and laboratory use only. It is not intended for human or veterinary consumption. Researchers are responsible for complying with all applicable regulations in their jurisdiction.